These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 19958769

  • 1. Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy.
    Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos D, Thomaidi A, Mitrousi K, Boudoulas H.
    Eur J Pharmacol; 2010 Feb 25; 628(1-3):164-70. PubMed ID: 19958769
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S, Danser AH, Foronjy RF, Oz MC, Wang J, Mancini D, D'Armiento J, Burkhoff D.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1166-74. PubMed ID: 17367660
    [Abstract] [Full Text] [Related]

  • 4. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B.
    J Am Coll Cardiol; 2004 Nov 16; 44(10):2019-26. PubMed ID: 15542286
    [Abstract] [Full Text] [Related]

  • 5. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, Heras M, Sanz G.
    Eur Heart J; 2000 Jan 16; 21(1):53-7. PubMed ID: 10610744
    [Abstract] [Full Text] [Related]

  • 6. Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure.
    Vittorio TJ, Ahuja K, Kasper M, Turalic H, Tseng CH, Jorde UP, Go C.
    J Renin Angiotensin Aldosterone Syst; 2007 Dec 16; 8(4):200-4. PubMed ID: 18205099
    [Abstract] [Full Text] [Related]

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 16; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High prevalence of microalbuminuria in chronic heart failure patients.
    van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA.
    J Card Fail; 2005 Oct 16; 11(8):602-6. PubMed ID: 16230263
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 16; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I, Rubonivich S, Azaz-Livshits T.
    Isr Med Assoc J; 2008 Mar 16; 10(3):214-8. PubMed ID: 18494235
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun 16; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial.
    Ekman I, Fagerberg B, Andersson B, Matejka G, Persson B.
    Heart Lung; 2003 Jun 16; 32(1):3-9. PubMed ID: 12571543
    [Abstract] [Full Text] [Related]

  • 16. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O, Beygui F, Vicaut E, Rouanet S, Van Belle E, Baulac C, Degrandsart A, Dallongeville J, Montalescot G, OPERA Investigators.
    Am J Cardiol; 2009 Oct 01; 104(7):904-9. PubMed ID: 19766754
    [Abstract] [Full Text] [Related]

  • 17. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G, Lauri G, Assanelli E, Grazi M, Guazzi M, Berna G, Salvioni A, Agostoni P.
    Cardiologia; 1997 Dec 01; 42(12):1277-83. PubMed ID: 9534323
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 01; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 19. Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy.
    García-Bolao I, López B, Macías A, Gavira JJ, Azcárate P, Díez J.
    Eur Heart J; 2008 Apr 01; 29(7):898-906. PubMed ID: 18334474
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
    Tribouilloy C, Rusinaru D, Leborgne L, Peltier M, Massy Z, Slama M.
    Am J Cardiol; 2008 Mar 01; 101(5):639-44. PubMed ID: 18308013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.